For treatment of: Avelox It is used to treat wounds, ulcers, bedsores, boils, burns, frostbite.Avelox moxifloxacin
- For the treatment of organs: nasal cavity, respiratory system, sexual system, skin.
- Appointment: antimicrobial agent is a fluoroquinolone.
- Indications for use:
Infectious and inflammatory diseases in adults caused by microorganisms sensitive to the drug:acute sinusitis; exacerbation of chronic bronchitis; community-acquired pneumonia (including those caused by strains of microorganisms with multiple antibiotic resistance*);uncomplicated infections of the skin and soft tissues; complicated infections of the skin and subcutaneous structures (including infected diabetic foot); complicated intraabdominal infections, including polymicrobial infections, including intraperitoneal abscesses; uncomplicated pelvic inflammatory diseases (including salpingitis and endometritis).
* Streptococcus pneumoniae with multiple antibiotic resistance include strains resistant to penicillin and strains resistant to two or more antibiotics from groups such as penicillins (at MIC ≥2 mg/ml), generation II cephalosporins (cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. It is necessary to take into account the current official guidelines on the rules for the use of antibacterial agents.
moxifloxacin hydrochloride – 436.8 mg, which corresponds to the content of moxifloxacin 400 mg.
Excipients: microcrystalline cellulose - 136 mg, croscarmellose sodium - 32 mg, lactose monohydrate - 68 mg, magnesium stearate - 6 mg.
The composition of the film shell: hypromellose - 9-12.6 mg, iron oxide red dye - 300-420 mcg, macrogol 4000 - 3-4.2 mg, titanium dioxide - 2.7-3.78 mg.